Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,682 | -17,886 | -9,812 | -9,538 | -9,742 |
| Depreciation Amortization | 194 | 781 | 591 | 407 | 208 |
| Accounts receivable | -2,464 | -5,212 | -6,999 | -9,145 | -5,559 |
| Accounts payable and accrued liabilities | 121 | 176 | -311 | 425 | -453 |
| Other Working Capital | -2,020 | -6,252 | -8,260 | -16,193 | -4,586 |
| Other Operating Activity | 4,688 | 10,766 | 11,755 | 11,323 | 7,455 |
| Operating Cash Flow | $-9,163 | $-17,627 | $-13,036 | $-22,721 | $-12,677 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -111 | -13,172 | -12,196 | -8,212 | -4,057 |
| Common Stock Issued | N/A | 49,757 | 0 | N/A | N/A |
| Other Financing Activity | -9 | -35,140 | 0 | 0 | 0 |
| Financing Cash Flow | $-120 | $1,445 | $-12,196 | $-8,212 | $-4,057 |
| Beginning Cash Position | 30,147 | 46,329 | 46,329 | 46,329 | 46,329 |
| End Cash Position | 20,864 | 30,147 | 21,097 | 15,396 | 29,595 |
| Net Cash Flow | $-9,283 | $-16,182 | $-25,232 | $-30,933 | $-16,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,163 | -17,627 | -13,036 | -22,721 | -12,677 |
| Free Cash Flow | -9,163 | -17,627 | -13,036 | -22,721 | -12,677 |